Mentioned in ?
References in periodicals archive ?
Flomax Hematological Procrit (epoetin alfa) Aranesp v.
Rising Drug Costs Drives the Growth of Pharmacy Benefit Managers Exclusion Lists: Are Exclusion Decisions Value-Based?
(NYSE: PFE) has received US Food and Drug Administration approval for Retacrit (epoetin alfa-epbx), a biosimilar to Epogen and Procrit (epoetin alfa), the company said.
US FDA Approves Pfizer Biosimilar Retacrit (epoetin alfa-epbx)
Pfizer announced the United States Food and Drug Administration approved RETACRIT, a biosimilar to Epogen and Procrit, for all indications of the reference product.
Pfizer biosimilar to Epogen and Procrit approved by FDA
Food and Drug Administration as the first "biosimilar" to the anemia drugs Epogen and Procrit.
FDA Approves 'Biosimilar' Drug to Treat Certain Types of Anemia; Retacrit is biosimilar to the drugs Epogen and Procrit
Among the drug class segments, erythropoietin stimulating agents, such as NeoRecormon, Procrit, and Arsanep, are expected to account for the largest share of the global cancer supportive care products market, followed by granulocyte colony-stimulating factors and others.
Global Cancer Supportive Care Products Market Will Reach US$ 31.7 Bn by 2021: Persistence Market Research
She also received Procrit for anemia and her hypertension and diabetes mellitus type II were controlled with Lasix, Lisinopril, Hydrochlorothiazide, and Metformin.
Chronic hepatitis C therapy in liver cirrhosis complicated by telaprevir-induced DRESS
My brands include Band-Aid, Listerine, Tylenol, Splenda, Motrin, Visine, Stayfree, K-Y, Rogaine, Procrit and Remicade.
Trivia
Together, they control a significant portion of the AIDS drug market with drugs that include Prezista, Intelence, Endurant and Procrit.
AHF SUES JOHNSON & JOHNSON FOR AIDS DRUG PRICING
Darbepoetin alfa, marketed as Arandesp, and epoetin alfa, marketed as Epogen o and Procrit, are the ESAs approved in the United States; they are administered as often as one to three times per week.
Option for anemia in CKD
The Food and Drug Administration released Friday reducing the dosage for anemia drugs Procrit, Epogen and Aranesp for patients with chronic kidney disease due to increased risks of stroke, blood clots and death.
Lower Doses of Anemia Drugs Recommended: FDA
The three antianemia drugs on the market (Procrit, Aranesp and Epogen) had combined sales of $6.3 billion last year.
Evidence-based medicine (except when they don't like the evidence)
In November 2008, the FDA approved a black-box warning for the labels of Procrit and Aranesp, the two ESAs in general use in the United States.
What you can do to optimize blood conservation in ObGyn practice: this institution's protocol is worth considering for identifying and correcting iron-deficiency anemia before delivery and elective gyn surgery. The goals? To avert complications and avoid transfusion

Dictionary browser ?
Full browser ?